Literature DB >> 24571489

Using viruses as nanomedicines.

H E van Kan-Davelaar1, J C M van Hest, J J L M Cornelissen, M S T Koay.   

Abstract

The field of nanomedicine involves the design and fabrication of novel nanocarriers for the intracellular delivery of therapeutic cargo or for use in molecular diagnostics. Although traditionally recognized for their ability to invade and infect host cells, viruses and bacteriophages have been engineered over the past decade as highly promising molecular platforms for the targeted delivery and treatment of many human diseases. Inherently biodegradable, the outer capsids of viruses are composed entirely of protein building blocks, which can be genetically or chemically engineered with molecular imaging reagents, targeting ligands and therapeutic molecules. While there are several examples of viruses as in vitro molecular cargo carriers, their potential for applications in nanomedicine has only recently emerged. Here we highlight recent developments towards the design and engineering of viruses for the treatment of cancer, bacterial infections and immune system-related diseases.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24571489      PMCID: PMC4243974          DOI: 10.1111/bph.12662

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  65 in total

Review 1.  The coming of age of virus-like particle vaccines.

Authors:  Gary T Jennings; Martin F Bachmann
Journal:  Biol Chem       Date:  2008-05       Impact factor: 3.915

Review 2.  Cadherins: a molecular family important in selective cell-cell adhesion.

Authors:  M Takeichi
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

3.  Systemic trafficking of plant virus nanoparticles in mice via the oral route.

Authors:  Chris S Rae; Ing Wei Khor; Qian Wang; Giuseppe Destito; Maria J Gonzalez; Pratik Singh; Diane M Thomas; Mayra N Estrada; Elizabeth Powell; M G Finn; Marianne Manchester
Journal:  Virology       Date:  2005-09-26       Impact factor: 3.616

4.  Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells.

Authors:  Nicole F Steinmetz; Choi-Fong Cho; Amber Ablack; John D Lewis; Marianne Manchester
Journal:  Nanomedicine (Lond)       Date:  2011-02       Impact factor: 5.307

5.  Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.

Authors:  Nicole F Steinmetz; Amber L Ablack; Jennifer L Hickey; Jailal Ablack; Bhavik Manocha; Joe S Mymryk; Leonard G Luyt; John D Lewis
Journal:  Small       Date:  2011-04-26       Impact factor: 13.281

6.  Evaluating efficacy of bacteriophage therapy against Staphylococcus aureus infections using a silkworm larval infection model.

Authors:  Iyo Takemura-Uchiyama; Jumpei Uchiyama; Shin-ichiro Kato; Tetsuyoshi Inoue; Takako Ujihara; Naoya Ohara; Masanori Daibata; Shigenobu Matsuzaki
Journal:  FEMS Microbiol Lett       Date:  2013-08-06       Impact factor: 2.742

7.  Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection.

Authors:  Leah P Shriver; Kristopher J Koudelka; Marianne Manchester
Journal:  J Neuroimmunol       Date:  2009-04-25       Impact factor: 3.478

8.  Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants.

Authors:  Keith Saunders; Frank Sainsbury; George P Lomonossoff
Journal:  Virology       Date:  2009-09-05       Impact factor: 3.616

9.  Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

Authors:  Pratik Singh; Duane Prasuhn; Robert M Yeh; Giuseppe Destito; Chris S Rae; Kent Osborn; M G Finn; Marianne Manchester
Journal:  J Control Release       Date:  2007-04-13       Impact factor: 9.776

10.  Canine parvovirus-like particles, a novel nanomaterial for tumor targeting.

Authors:  Pratik Singh; Giuseppe Destito; Anette Schneemann; Marianne Manchester
Journal:  J Nanobiotechnology       Date:  2006-02-13       Impact factor: 10.435

View more
  13 in total

Review 1.  Nano-enabled delivery of diverse payloads across complex biological barriers.

Authors:  Kathleen A Ross; Timothy M Brenza; Andrea M Binnebose; Yashdeep Phanse; Anumantha G Kanthasamy; Howard E Gendelman; Aliasger K Salem; Lyric C Bartholomay; Bryan H Bellaire; Balaji Narasimhan
Journal:  J Control Release       Date:  2015-08-24       Impact factor: 9.776

2.  Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages.

Authors:  Michael A Bruckman; Lauren N Randolph; Neetu M Gulati; Phoebe L Stewart; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2015-07-22       Impact factor: 6.331

Review 3.  Plant Viruses and Bacteriophage-Based Reagents for Diagnosis and Therapy.

Authors:  Sourabh Shukla; He Hu; Hui Cai; Soo-Khim Chan; Christine E Boone; Veronique Beiss; Paul L Chariou; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2020-09-29       Impact factor: 10.431

4.  Special issue of BJP on nanomedicine.

Authors:  Andrew Owen
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

5.  Recognition of extremophilic archaeal viruses by eukaryotic cells: a promising nanoplatform from the third domain of life.

Authors:  Kristine Buch Uldahl; Linping Wu; Arnaldur Hall; Pavlos Papathanasiou; Xu Peng; Seyed Moein Moghimi
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

Review 6.  Synthetic plant virology for nanobiotechnology and nanomedicine.

Authors:  John F C Steele; Hadrien Peyret; Keith Saunders; Roger Castells-Graells; Johanna Marsian; Yulia Meshcheriakova; George P Lomonossoff
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-01-11

Review 7.  Bioengineering Strategies for Protein-Based Nanoparticles.

Authors:  Dennis Diaz; Andrew Care; Anwar Sunna
Journal:  Genes (Basel)       Date:  2018-07-23       Impact factor: 4.096

8.  Capacitive Field-Effect Biosensor Studying Adsorption of Tobacco Mosaic Virus Particles.

Authors:  Melanie Jablonski; Arshak Poghossian; Robin Severins; Michael Keusgen; Christina Wege; Michael J Schöning
Journal:  Micromachines (Basel)       Date:  2021-01-06       Impact factor: 2.891

Review 9.  Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies.

Authors:  Katherine M Nelson; N'Dea Irvin-Choy; Matthew K Hoffman; Jason P Gleghorn; Emily S Day
Journal:  Adv Drug Deliv Rev       Date:  2020-09-28       Impact factor: 15.470

Review 10.  Phage display as a promising approach for vaccine development.

Authors:  Leili Aghebati-Maleki; Babak Bakhshinejad; Behzad Baradaran; Morteza Motallebnezhad; Ali Aghebati-Maleki; Hamid Nickho; Mehdi Yousefi; Jafar Majidi
Journal:  J Biomed Sci       Date:  2016-09-29       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.